PMS-CONJUGATED ESTROGENS C.S.D. TABLET

Country: Kanada

Tungumál: enska

Heimild: Health Canada

Virkt innihaldsefni:

CONJUGATED ESTROGENS

Fáanlegur frá:

PHARMASCIENCE INC

ATC númer:

G03CA57

INN (Alþjóðlegt nafn):

CONJUGATED ESTROGENS

Skammtar:

1.25MG

Lyfjaform:

TABLET

Samsetning:

CONJUGATED ESTROGENS 1.25MG

Stjórnsýsluleið:

ORAL

Einingar í pakka:

100/1000

Gerð lyfseðils:

Prescription

Lækningarsvæði:

ESTROGENS

Vörulýsing:

Active ingredient group (AIG) number: 0106442003; AHFS:

Leyfisstaða:

CANCELLED POST MARKET

Leyfisdagur:

2017-09-30

Vara einkenni

_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 1 of 42 _
_ _
PRODUCT MONOGRAPH
PR
PMS-CONJUGATED ESTROGENS CSD
(conjugated estrogens tablets, CSD)
0.3 mg, 0.625 mg, 0.9 mg, and 1.25 mg
ESTROGENIC HORMONES
PHARMASCIENCE INC.
DATE OF REVISION:
6111 Royalmount Avenue, Suite 100
AUGUST 28, 2009
Montreal, Quebec
H4P 2T4
CONTROL NUMBER: 120633
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 2 of 42 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION……………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………….3
INDICATIONS AND CLINICAL
USE…………………………………………...3
CONTRAINDICATIONS…………………………………………………………4
WARNINGS AND
PRECAUTIONS…………………………………….……….5
ADVERSE
REACTIONS………………………………………………………...13
DRUG
INTERACTIONS………………………………………………………...18
DOSAGE AND
ADMINISTRATION…………………………………………...20
OVERDOSAGE………………………………………………………………….22
ACTION AND CLINICAL
PHARMACOLOGY……………………………….23
STORAGE AND
STABILITY…………………………………………………...26
SPECIAL HANDLING
INSTRUCTIONS………………………………………26
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..26
PART II: SCIENTIFIC
INFORMATION…………………………………………….
27
PHARMACEUTICAL
INFORMATION………………………………………...27
CLINICAL
TRIALS……………………………………………………………...27
DETAILED
PHARMACOLOGY………………………………………………..32
REFERENCES…………………………………………………………………...33
PART III: CONSUMER
INFORMATION……………………………………………………
37
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_